About FDA
Number of new inquires received in the month
Dictionary: In this measure, the Office of Compliance (OC) is tracking interactions with its stakeholders: regulated firms, trade groups, interest groups, and individual consumers. Congressional and press inquiries also are part of our workload but are tracked by other offices in CDER. Industry and consumer inquiries come into OC through public email addresses, phone calls, and occasionally by letter. Inquiries are answered by OC's staff and analyzed for patterns that may indicate the need for outreach activities or development of guidance.
This measure has been retired as CDER has created new measures for FY13 which align to their four functional areas of 1) Regulatory Review and Drug Safety, 2) Drug Quality and Compliance, 3) Transparency and Public Outreach, and 4) Regulatory Science Research.
Fiscal Year - 2011
| Time | Target | Number |
|---|---|---|
| Oct 2010 | N/A | 178 |
| Nov 2010 | N/A | 168 |
| Dec 2010 | N/A | 125 |
| Jan 2011 | N/A | 166 |
| Feb 2011 | N/A | 230 |
| Mar 2011 | N/A | 191 |
| Apr 2011 | N/A | 172 |
| May 2011 | N/A | 158 |
| Jun 2011 | N/A | 155 |
| Jul 2011 | N/A | 187 |
| Aug 2011 | N/A | 256 |
| Sep 2011 | N/A | 226 |
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
